Skip to main content
An official website of the United States government
The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Search:
Agenda
Reg Review
ICR
This script is used to control the display of information in this page.
Display additional information by clicking on the following:
All
Brief and OIRA conclusion
Abstract/Justification
Legal Statutes
Rulemaking
FR Notices/Comments
IC List
Burden
Misc.
Common Form Info.
Certification
View Information Collection (IC) List
View Supporting Statement and Other Documents
Please note that the OMB number and expiration date may not have been determined when this Information Collection Request and associated Information Collection forms were submitted to OMB. The approved OMB number and expiration date may be found by clicking on the Notice of Action link below.
View ICR - OIRA Conclusion
OMB Control No:
0938-0964
ICR Reference No:
201008-0938-020
Status:
Historical Active
Previous ICR Reference No:
200905-0938-002
Agency/Subagency:
HHS/CMS
Agency Tracking No:
Title:
Medicare Prescription Drug Benefit Program
Type of Information Collection:
Revision of a currently approved collection
Common Form ICR:
No
Type of Review Request:
Regular
OIRA Conclusion Action:
Approved without change
Conclusion Date:
01/10/2011
Retrieve Notice of Action (NOA)
Date Received in OIRA:
08/30/2010
Terms of Clearance:
Though this ICR is approved for 3 years, CMS is reminded that any substantive changes that occur because of agency discretion (e.g. due to changes in the annual Call Letter or 45 day Advance Notice) must be approved before the changes are implemented. Changes that are implemented prior to ICR approval will be considered PRA violations.
Inventory as of this Action
Requested
Previously Approved
Expiration Date
01/31/2014
36 Months From Approved
09/30/2012
Responses
43,153,271
0
38,152,764
Time Burden (Hours)
36,520,101
0
34,730,676
Cost Burden (Dollars)
0
0
0
Abstract:
The voluntary prescription drug benefit program was enacted into law on December 8, 2003 in section 101 of Title I of the Medicare Prescription Drug, Improvement, and Modernization Act of 2003 (MMA). The MMA specifies that the prescription drug benefit program will be available to beneficiaries on January 1, 2006. Coverage for the prescription drug benefit will be provided under private prescription drug plans, or through Medicare Advantage prescription drug plans. Organizations offering drug plans will have flexibility in the design of the prescription drug benefit.
Authorizing Statute(s):
Statute at Large:
18 Stat. 1860
Citations for New Statutory Requirements:
Statute at Large: 18 Stat. 1860
Associated Rulemaking Information
RIN:
Stage of Rulemaking:
Federal Register Citation:
Date:
0938-AP77
Final or interim final rulemaking
75 FR 19678
04/15/2010
Federal Register Notices & Comments
60-day Notice:
Federal Register Citation:
Citation Date:
75 FR 20365
04/19/2010
30-day Notice:
Federal Register Citation:
Citation Date:
75 FR 43168
07/23/2010
Did the Agency receive public comments on this ICR?
Yes
Number of Information Collection (IC) in this ICR:
2
IC Title
Form No.
Form Name
Medicare Prescription Drug Benefit Program (PLAN)-(CMS-10141)
Medicare Prescription Drug Benefit Program (Benes)
ICR Summary of Burden
Total Approved
Previously Approved
Change Due to New Statute
Change Due to Agency Discretion
Change Due to Adjustment in Estimate
Change Due to Potential Violation of the PRA
Annual Number of Responses
43,153,271
38,152,764
4,973,234
27,273
0
0
Annual Time Burden (Hours)
36,520,101
34,730,676
1,775,489
13,936
0
0
Annual Cost Burden (Dollars)
0
0
0
0
0
0
Burden increases because of Program Change due to Agency Discretion:
Yes
Burden Increase Due to:
Changing Regulations
Burden decreases because of Program Change due to Agency Discretion:
No
Burden Reduction Due to:
Short Statement:
MDBG - 423.48, 423.104, 423.120(b), 423.128 (a) (e), 423.153 (b) (c) (d), 423.505(d) (f) 423.800 (b.) The increase in burden occurred because of the increased number of respondents (Part D sponsors) participating in the program. The estimated burden per respondent has generally remained the same from the initial estimates. Also, some burden estimates under the original package have been subsumed under other collection packages. The increase in burden associated with 423.153(d) is associated with the burden associated with the MTM requirement. The new requirement which requires sponsors to perform MTMP that at least include interventions for beneficiaries and prescribers, annual comprehensive reviews and quarterly targeted medication reviews. MEAG - 423.562, 423.564, 423.568, 423.570, 423.572, 423.578, 423.580, 423.582, 423.584, 423.590. The increase in burden occurred because of new notice requirements created in CMS-4085-F. Other changes to burden requirements were due to a decrease in the number of Part D plans.
Annual Cost to Federal Government:
$200,000
Does this IC contain surveys, censuses, or employ statistical methods?
No
Is the Supporting Statement intended to be a Privacy Impact Assessment required by the E-Government Act of 2002?
No
Is this ICR related to the Affordable Care Act [Pub. L. 111-148 & 111-152]?
No
Is this ICR related to the Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]?
No
Is this ICR related to the American Recovery and Reinvestment Act of 2009 (ARRA)?
No
Is this ICR related to the Pandemic Response?
Uncollected
Agency Contact:
Bonnie Harkless 4107865666
Common Form ICR:
No
On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
(a) It is necessary for the proper performance of agency functions;
(b) It avoids unnecessary duplication;
(c) It reduces burden on small entities;
(d) It uses plain, coherent, and unambiguous language that is understandable to respondents;
(e) Its implementation will be consistent and compatible with current reporting and recordkeeping practices;
(f) It indicates the retention periods for recordkeeping requirements;
(g) It informs respondents of the information called for under 5 CFR 1320.8 (b)(3) about:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control number;
(h) It was developed by an office that has planned and allocated resources for the efficient and effective management and use of the information to be collected.
(i) It uses effective and efficient statistical survey methodology (if applicable); and
(j) It makes appropriate use of information technology.
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.
Certification Date:
08/30/2010
An official website of the United States government
The .gov means it's official.
The site is secure.
